A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes | Zendy

Walid Fakhoury | Zendy; C LeReun | Zendy; Donna Wright | Zendy

Open Access

A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes

Author(s) -

Walid Fakhoury,

C LeReun,

Donna Wright

Publication year - 2010

Publication title -

pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.51

H-Index - 59

eISSN - 1423-0313

pISSN - 0031-7012

DOI - 10.1159/000314690

Subject(s) - sitagliptin , exenatide , vildagliptin , medicine , liraglutide , placebo , type 2 diabetes , incretin , diabetes mellitus , confidence interval , sitagliptin phosphate , meta analysis , randomized controlled trial , gastroenterology , endocrinology , alternative medicine , pathology

A systematic review of the literature, in combination with a meta-analysis of randomized controlled trials comparing treatments with placebo, was conducted to provide an update on the clinical efficacy and safety of incretin-based medications in adult patients with type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research